ArticleBMC medical imaging2026
Nomogram based on quantitative lung CT features to identify cardiovascular disease in chronic obstructive pulmonary disease and predict prognosis.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectivesTo explore the performance of a CT-derived lung nomogram for identifying cardiovascular disease (CVD) among individuals with chronic obstructive pulmonary disease (COPD) and assessing the relationship with COPD prognosis.
methodsThis retrospective analysis enrolled hospitalized COPD patients between September 2015 and April 2023, with clinical data and visually assessed coronary artery calcium scores (CACS) collected for all participants. A quantitative model was constructed by extracting features from lung CT images and employing the least absolute shrinkage and selection operator algorithm for feature selection. The quantitative features and clinical factors were merged to formulate a nomogram. Area under the ROC curve (AUC) and decision curve analysis were used to study the ability of the nomogram to identify prevalent CVD. In Kaplan-Meier analysis, the predictive value of the nomogram for COPD re-hospitalization and all-cause mortality as endpoints was studied.
resultsOf 643 COPD patients (mean age, 68 years ± 10[SD]; 110 female), 159 had a history of CVD. The derived nomogram had better ability to identify CVD (AUC: 0.87; 95%CI 0.78, 0.94) than the clinical factors alone (AUC: 0.75; 95%CI 0.63, 0.86) and visual CACS (AUC: 0.68; 95%CI 0.56, 0.79) in internal validation, and achieved good performance in external validation with highest AUC (0.77; 95%CI 0.71, 0.84). The nomogram demonstrated a strong association with events (P < 0.001).
conclusionA nomogram based on quantitative CT features and clinical factors could effectively identify CVD in COPD patients, with bette discriminatory capacity than visual CACS or clinical factors alone. The nomogram also showed association with COPD re-hospitalization and all-cause mortality.
trial registrationIn accordance with the Declaration of Helsinki, this retrospective study was approved (Ethical Approval: Second Affiliated Hospital of Naval Medical University Ethics Committee, 2022SL068, December 6, 2022; Trial Registration: Chinese Clinical Trial Registry, ChiCTR2300069929, March 29, 2023), with a waiver for individual patient consent requirements.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.